TY - JOUR
T1 - Role of microparticles in dengue virus infection and its impact on medical intervention strategies
AU - Clark, Kristina Bargeron
AU - Hsiao, Hui Mien
AU - Noisakran, Sansanee
AU - Tsai, Jih Jin
AU - Perng, Guey Chuen
PY - 2012/3
Y1 - 2012/3
N2 - Dengue virus (DV†) is one of the most important vector-borne diseases in the world. It causes a disease that manifests as a spectrum of clinical symptoms, including dengue hemorrhagic fever. DV is proficient at diverting the immune system to facilitate transmission through its vector host, Aedes spp. mosquito. Similar to other vector-borne parasites, dengue may also require a second structural form, a virus of alternative morphology (VAM), to complete its life cycle. DV can replicate to high copy numbers in patient plasma, but no classical viral particles can be detected by ultra-structural microscopy analysis. A VAM appearing as a microparticle has been recapitulated with in vitro cell lines Meg01 and K562, close relatives to the cells harboring dengue virus in vivo. VAMs are likely to contribute to the high viremia levels observed in dengue patients. This review discusses the possible existence of a VAM in the DV life cycle.
AB - Dengue virus (DV†) is one of the most important vector-borne diseases in the world. It causes a disease that manifests as a spectrum of clinical symptoms, including dengue hemorrhagic fever. DV is proficient at diverting the immune system to facilitate transmission through its vector host, Aedes spp. mosquito. Similar to other vector-borne parasites, dengue may also require a second structural form, a virus of alternative morphology (VAM), to complete its life cycle. DV can replicate to high copy numbers in patient plasma, but no classical viral particles can be detected by ultra-structural microscopy analysis. A VAM appearing as a microparticle has been recapitulated with in vitro cell lines Meg01 and K562, close relatives to the cells harboring dengue virus in vivo. VAMs are likely to contribute to the high viremia levels observed in dengue patients. This review discusses the possible existence of a VAM in the DV life cycle.
UR - http://www.scopus.com/inward/record.url?scp=84859296706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859296706&partnerID=8YFLogxK
M3 - Article
C2 - 22461739
AN - SCOPUS:84859296706
SN - 0044-0086
VL - 85
SP - 3
EP - 18
JO - Yale Journal of Biology and Medicine
JF - Yale Journal of Biology and Medicine
IS - 1
ER -